康能生物 (831754.OC)

+ 收藏

现金流量表(康能生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年三季报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 20,273,696.3040,660,505.1518,934,775.3130,765,789.6223,090,176.1115,648,574.64
 收到其他与经营活动有关的现金(元) 11,256,169.54936,494.235,519,569.311,597,150.89775,675.514,928,186.88
 经营活动现金流入小计(元) 31,529,865.8441,596,999.3824,454,344.6232,362,940.5123,865,851.6220,576,761.52
 购买商品、接受劳务支付的现金(元) 28,124,453.4917,254,630.9614,181,579.0619,534,548.8516,670,470.1510,958,202.02
 支付给职工以及为职工支付的现金(元) 7,306,585.5812,454,116.095,663,827.4610,500,270.695,989,631.525,264,632.80
 支付的各项税费(元) 727,069.58433,250.91288,962.85260,093.74173,673.29231,236.78
 支付其他与经营活动有关的现金(元) 1,267,196.208,300,351.311,211,555.904,303,372.273,301,894.511,395,178.81
 经营活动现金流出小计(元) 37,425,304.8538,442,349.2721,345,925.2734,598,285.5526,135,669.4717,849,250.41
 经营活动产生的现金流量净额(元) -5,895,439.013,154,650.113,108,419.35-2,235,345.04-2,269,817.852,727,511.11
二、投资活动产生的现金流量
 处置子公司及其他营业单位收到的现金净额(元) ---6,000,000.004,200,000.00-
 投资活动现金流入小计(元) ---6,000,000.004,200,000.00-
 购建固定资产、无形资产和其他长期资产支付的现金(元) -754,881.21156,529.00757,548.0067,308.00780,828.60
 投资活动现金流出小计(元) -754,881.21156,529.00757,548.0067,308.00780,828.60
 投资活动产生的现金流量净额(元) --754,881.21-156,529.005,242,452.004,132,692.00-780,828.60
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 21,800,000.0036,300,000.00-13,840,000.0013,300,000.00-
 收到其他与筹资活动有关的现金(元) -18,913,378.44-4,905,800.0015,533,000.00-
 筹资活动现金流入小计(元) 21,800,000.0055,213,378.44-18,745,800.0028,833,000.00-
 偿还债务支付的现金(元) 13,688,739.2733,570,000.00203,468.9416,061,581.3914,638,722.76945,616.90
 分配股利、利润或偿付利息支付的现金(元) 767,555.893,194,416.892,222,289.581,345,973.201,207,820.511,390,211.28
 支付其他与筹资活动有关的现金(元) -18,918,728.52-4,992,261.4615,455,183.81-
 筹资活动现金流出小计(元) 14,456,295.1655,683,145.412,425,758.5222,399,816.0531,301,727.082,335,828.18
 筹资活动产生的现金流量净额(元) 7,343,704.84-469,766.97-2,425,758.52-3,654,016.05-2,468,727.08-2,335,828.18
五、现金及现金等价物净增加额(元) 1,448,265.831,930,001.93526,131.83-646,909.09-605,852.93-389,145.67
 加:期初现金及现金等价物余额(元) 787,472.01261,340.18261,340.18908,249.27908,249.27908,249.27
 期末现金及现金等价物余额(元) 2,235,737.842,191,342.11787,472.01261,340.18302,396.34519,103.60
补充资料:
 净利润(元) 3,006,019.435,101,659.042,980,454.10-2,989,644.04--837,150.98
 固定资产和投资性房地产折旧(元) 3,652,104.536,895,993.464,173,437.726,926,705.13-3,662,079.69
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 3,652,104.536,895,993.464,173,437.726,926,705.13-3,662,079.69
 无形资产摊销(元) 74,882.14149,764.3274,882.14149,764.32-74,882.14
 长期待摊费用摊销(元) -70,786.68-70,786.67--
 固定资产报废损失(元) -2,578.35----
 财务费用(元) 1,057,869.782,568,872.93883,485.891,532,738.37-1,393,711.02
 存货的减少(元) -10,756,448.61-3,299,653.10-97,980.27-12,051,936.52--7,473,185.26
 经营性应收项目的减少(元) -447,178.88-2,241,308.83-2,044,936.2571,379.84--718,609.65
 经营性应付项目的增加(元) -2,482,687.40-6,723,634.36-3,118,687.403,153,009.33-6,548,956.45
 现金的期末余额(元) 2,235,737.842,191,342.11787,472.01261,340.18-519,103.60
 减:现金的期初余额(元) 2,191,342.11261,340.18261,340.18908,249.27-933,516.56
 现金及现金等价物的净增加额(元) 44,395.731,930,001.93526,131.83-646,909.09--414,412.96
公告日期 2024-08-222024-04-082023-07-282023-04-212023-02-092022-08-16
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院